Cigna Drops Humana Merger, Opts For $10 Billion Buyback Strategy
Portfolio Pulse from Bibhu Pattnaik
Cigna Corporation (NYSE:CI) has decided to abandon its proposed merger with Humana Inc. (NYSE:HUM) due to disagreements over financial terms. Instead, Cigna is shifting its focus to smaller acquisitions and has announced a $10 billion stock buyback program, increasing its total planned buybacks to $11.3 billion. The company remains positive about the benefits of a partnership with Humana and plans to repurchase at least $5 billion of common stock by mid-2024. The collapse of the deal leaves Cigna evaluating the sale of its Medicare Advantage business while continuing to expand its Evernorth health services unit.
December 10, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Humana Inc. was involved in a proposed merger with Cigna, which has now been abandoned.
The cancellation of the merger might be viewed negatively by investors who were anticipating the benefits of the combined entity, potentially leading to a short-term decrease in Humana's stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
NEUTRAL IMPACT
Elevance Health Inc could be indirectly affected by the Cigna-Humana merger news.
Elevance Health Inc, as a competitor in the health insurance market, may see some stock movement due to the Cigna-Humana deal news, but the impact is expected to be minor.
CONFIDENCE 70
IMPORTANCE 40
RELEVANCE 30
NEUTRAL IMPACT
The iShares U.S. Healthcare ETF (IYH) may be impacted by the industry news surrounding the Cigna-Humana deal.
IYH, as a healthcare ETF, may have a muted response to the Cigna-Humana news, given its broad exposure to the healthcare sector.
CONFIDENCE 60
IMPORTANCE 30
RELEVANCE 20
NEUTRAL IMPACT
UnitedHealth Group Inc. may experience stock movement due to industry developments related to the Cigna-Humana deal.
As a related stock in the health insurance sector, UnitedHealth Group could see some indirect impact, but the effect is likely to be limited and more speculative.
CONFIDENCE 70
IMPORTANCE 40
RELEVANCE 30
NEUTRAL IMPACT
The Health Care Select Sector SPDR Fund (XLV) could see changes due to the Cigna-Humana merger news.
As an ETF that includes health care stocks, XLV could experience some movement due to the news, but as a diversified fund, the impact is likely to be diluted.
CONFIDENCE 60
IMPORTANCE 30
RELEVANCE 20
POSITIVE IMPACT
Cigna Corporation has pulled out of the Humana merger and announced a $10 billion stock buyback program.
The termination of the merger and the announcement of a significant stock buyback program could be seen positively by investors, potentially leading to a short-term increase in Cigna's stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100